Bailey Fisher’s Private Markets Dinner is a peer-to-peer forum for owner managed, privately owned, private equity backed and listed company leaders to meet for dinner and discussion on issues of relevance to their role. Dinners are hosted by Andrew Moore, Partner and Head of the Private Markets Practice.
Our guest speaker is Shirin Dehghan, who has led winning teams within start-up, SME and larger corporates. As Founder/CEO of Arieso, Shirin led the growth of the company to exit to JDSU in 2013. Shirin is now Chairwoman of Opensignal, and a Senior Partner at Frog Capital, the London based European VC focused on scale up stage companies.
Experts at the table are Ian Tomlinson (Chair – Stevenage Bioscience Cataylst); Shaun Grady (VP – AstraZeneca) & Nooman Haque (MD Life Sciences at Silicon Valley Bank UK).
Jenny has over 20 years’ experience facilitating SME access to investment in the UK & internationally. At UKBAA she focuses on building the angel community around the UK, connecting investors to good deal flow and assisting entrepreneurs to attract investors. Jenny was awarded an OBE in 2015 for services to small businesses.
Nicola leads a team of university specialists covering Mercia’s 19 partnerships. She has a wealth of experience in life sciences and university commercialisation, having founded her own IP commercialisation company, and having spent 10 years as Commercial Director for a University of Leeds spin-out.
Steve has 30 years’ experience in marketing for brand and business growth and has developed marketing programmes for the likes of Nestle UK, Adnams plc and Kettle Chips. Steve led discussion around ‘The impact of brand identity within family firms’.
Dinner & discussion with Sue Wilson, Director at PwC, specialising in executive and employee reward. Sue has extensive experience in remuneration and equity incentives within the technology sector.
Shaun has global responsibility for Strategic Partnering & Business Development, dedicated to broadening AstraZeneca’s access to scientific innovation outside its own labs. His background includes ICI, Zeneca, and AstraZeneca in Corporate, Pharmaceuticals & US Legal departments, HR & Business Development. Major projects include the AstraZeneca merger, creation of Avecia & Syngenta, acquisition of Cambridge Antibody Technology, MedImmune & Amylin, and the spin out of Albireo.
We are assembling a panel of speakers to include Professor Rose Luckin of UCL Knowledge Lab, an expert in the use of Artificial Intelligence within EdTech.
Richard is a serial entrepreneur, CEO, board member and adviser to businesses at the cutting edge of technology, with extensive experience of growing businesses and leading teams to achieve their full potential. Richard led discussion around ‘Share options: how to incentivise your team’ alongside Neil Pearson, Partner at Mills & Reeve specialising in advising on share incentives for employees.